Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ECYT
Delisted

Endocyte Fund Price (Quote)

$23.99
+0 (+0%)
At Close: Jan 18, 2019

Range Low Price High Price Comment
30 days $23.97 $24.00 Friday, 18th Jan 2019 ECYT stock ended at $23.99. During the day the stock fluctuated 0% from a day low at $23.99 to a day high of $23.99.
90 days $23.37 $24.00
52 weeks $2.81 $24.00

Historical Endocyte prices

Date Open High Low Close Volume
Jul 20, 2018 $17.16 $17.69 $17.10 $17.33 808 298
Jul 19, 2018 $16.63 $17.26 $16.63 $17.10 684 131
Jul 18, 2018 $16.75 $17.01 $16.32 $16.80 677 238
Jul 17, 2018 $16.50 $17.05 $16.50 $16.93 640 768
Jul 16, 2018 $17.63 $17.70 $16.04 $16.50 930 858
Jul 13, 2018 $17.20 $17.47 $16.97 $17.26 534 692
Jul 12, 2018 $16.94 $17.42 $16.45 $17.34 799 990
Jul 11, 2018 $16.24 $16.92 $16.01 $16.75 545 639
Jul 10, 2018 $16.45 $16.92 $16.22 $16.46 892 230
Jul 09, 2018 $16.33 $16.52 $15.71 $16.50 1 243 446
Jul 06, 2018 $16.04 $16.71 $15.20 $16.01 2 370 533
Jul 05, 2018 $13.62 $15.86 $13.62 $15.62 2 352 119
Jul 03, 2018 $14.18 $14.23 $13.48 $13.60 1 512 794
Jul 02, 2018 $13.81 $14.30 $13.47 $14.14 910 004
Jun 29, 2018 $13.79 $14.26 $13.19 $13.80 1 468 427
Jun 28, 2018 $14.30 $14.43 $13.64 $13.67 1 032 888
Jun 27, 2018 $14.30 $15.08 $14.25 $14.26 1 413 080
Jun 26, 2018 $13.71 $14.74 $13.44 $14.45 1 416 568
Jun 25, 2018 $13.99 $14.01 $13.07 $13.64 1 065 121
Jun 22, 2018 $14.20 $14.25 $12.76 $13.79 9 287 705
Jun 21, 2018 $14.68 $15.00 $14.04 $14.12 1 363 706
Jun 20, 2018 $14.19 $14.80 $14.10 $14.64 1 128 524
Jun 19, 2018 $14.44 $14.49 $13.63 $14.15 1 284 900
Jun 18, 2018 $14.35 $14.66 $14.01 $14.52 1 043 836
Jun 15, 2018 $14.41 $14.62 $14.03 $14.36 1 653 026
Click to get the best stock tips daily for free!

About Endocyte

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trials to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of ad... ECYT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT